KCM
Kynam Capital Management Portfolio holdings
AUM
$929M
This Quarter Return
+7.46%
1 Year Return
-7.66%
3 Year Return
+163.82%
5 Year Return
–
10 Year Return
–
AUM
$773M
AUM Growth
+$773M
(+19%)
Cap. Flow
+$131M
Cap. Flow
% of AUM
16.91%
Top 10 Holdings %
Top 10 Hldgs %
77.51%
Holding
39
New
7
Increased
12
Reduced
14
Closed
4
Top Buys
| 1 |
TSVT
2seventy bio
TSVT
|
$38.1M |
| 2 |
Travere Therapeutics
TVTX
|
$25.8M |
| 3 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$20.2M |
| 4 |
Protagonist Therapeutics
PTGX
|
$19.6M |
| 5 |
Vaxcyte
PCVX
|
$19.2M |
Top Sells
| 1 |
United Therapeutics
UTHR
|
$27.8M |
| 2 |
CNCE
Concert Pharmaceuticals, Inc.
CNCE
|
$25.8M |
| 3 |
Apellis Pharmaceuticals
APLS
|
$15.5M |
| 4 |
Viridian Therapeutics
VRDN
|
$12.5M |
| 5 |
Celldex Therapeutics
CLDX
|
$7.05M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Natera
NTRA
$23.1B
| $162M | 20.92% | 2,918,237 +315,030 | +12% | +$17.5M |
|
|
HZNP
2
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $119M | 15.42% | 1,094,620 -5,380 | -0.5% | -$587K |
|
3
Syndax Pharmaceuticals
SNDX
$1.41B
| $67.7M | 8.74% | 3,205,986 +644,799 | +25% | +$13.6M |
|
|
4
Celldex Therapeutics
CLDX
$1.47B
| $50.7M | 6.55% | 1,409,451 -195,939 | -12% | -$7.05M |
|
|
5
Vaxcyte
PCVX
$4B
| $45.6M | 5.89% | 1,216,784 +513,343 | +73% | +$19.2M |
|
|
TSVT
6
DELISTED
2seventy bio
TSVT
| $38.1M | 4.92% | +3,738,972 | New | +$38.1M |
|
|
7
Travere Therapeutics
TVTX
$1.56B
| $35.2M | 4.54% | 1,563,595 +1,145,496 | +274% | +$25.8M |
|
|
8
Protagonist Therapeutics
PTGX
$3.67B
| $31.6M | 4.08% | 1,375,000 +854,078 | +164% | +$19.6M |
|
9
Vera Therapeutics
VERA
$1.38B
| $26.2M | 3.38% | 3,372,428 +1,963,330 | +139% | +$15.2M |
|
|
BNR
10
Burning Rock Biotech
BNR
$93.6M
| $22.5M | 2.91% | 8,020,625 +629,044 | +9% | +$1.77M |
|
|
SGEN
11
DELISTED
Seagen Inc. Common Stock
SGEN
| $20.2M | 2.61% | +100,000 | New | +$20.2M |
|
|
MRTX
12
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $18.6M | 2.4% | 499,853 +308,695 | +161% | +$11.5M |
|
|
AMRN
13
Amarin Corp
AMRN
$311M
| $18M | 2.32% | 12,000,000 +2,357,760 | +24% | +$3.54M |
|
14
GSK
GSK
$79.9B
| $17.7M | 2.29% | 498,329 -3,314 | -0.7% | -$118K |
|
15
Wave Life Sciences
WVE
$1.53B
| $16.5M | 2.13% | 3,807,876 +2,569,694 | +208% | +$11.1M |
|
|
16
Viridian Therapeutics
VRDN
$1.5B
| $13.8M | 1.79% | 543,603 -491,094 | -47% | -$12.5M |
|
17
Liquidia Corp
LQDA
$2.38B
| $11.3M | 1.46% | 1,642,244 -110,597 | -6% | -$764K |
|
18
Iovance Biotherapeutics
IOVA
$807M
| $11M | 1.42% | +1,800,000 | New | +$11M |
|
19
BioCryst Pharmaceuticals
BCRX
$1.74B
| $8.34M | 1.08% | +1,000,000 | New | +$8.34M |
|
20
Allogene Therapeutics
ALLO
$251M
| $7.39M | 0.95% | 1,495,981 +1,099,603 | +277% | +$5.43M |
|
21
Olema Pharmaceuticals
OLMA
$375M
| $6.98M | 0.9% | 2,011,853 -13,381 | -0.7% | -$46.4K |
|
22
Seres Therapeutics
MCRB
$166M
| $4.36M | 0.56% | 768,913 -7,749 | -1% | -$43.9K |
|
23
Cogent Biosciences
COGT
$1.69B
| $4.32M | 0.56% | 399,974 -394,075 | -50% | -$4.25M |
|
24
Sutro Biopharma
STRO
$72.7M
| $4.17M | 0.54% | 901,836 +497,292 | +123% | +$2.3M |
|
|
CNTA
25
Centessa Pharmaceuticals
CNTA
$2.25B
| $2.81M | 0.36% | 729,077 -4,849 | -0.7% | -$18.7K |
|